Mustang Bio MBIO Stock
Mustang Bio Price Chart
Mustang Bio MBIO Financial and Trading Overview
| Mustang Bio stock price | 0.7 USD |
| Previous Close | 0.65 USD |
| Open | 0.67 USD |
| Bid | 0.47 USD x 200 |
| Ask | 0.85 USD x 200 |
| Day's Range | 0.64 - 0.67 USD |
| 52 Week Range | 0.53 - 7 USD |
| Volume | 28.27K USD |
| Avg. Volume | 132.58K USD |
| Market Cap | 5.11M USD |
| Beta (5Y Monthly) | 2.079 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MBIO Valuation Measures
| Enterprise Value | -11151247 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.9257144 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.5938326 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 3.454 |
Trading Information
Mustang Bio Stock Price History
| Beta (5Y Monthly) | 2.079 |
| 52-Week Change | -37.59% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 7 USD |
| 52 Week Low | 0.53 USD |
| 50-Day Moving Average | 0.71 USD |
| 200-Day Moving Average | 1.06 USD |
MBIO Share Statistics
| Avg. Volume (3 month) | 132.58K USD |
| Avg. Daily Volume (10-Days) | 92.31K USD |
| Shares Outstanding | 6.73M |
| Float | 5.35M |
| Short Ratio | 1.28 |
| % Held by Insiders | 4.29% |
| % Held by Institutions | 9.46% |
| Shares Short | 54.57K |
| Short % of Float | 0.80% |
| Short % of Shares Outstanding | 0.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.84% |
| Return on Equity (ttm) | -44.62% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3228500 USD |
| Net Income Avi to Common (ttm) | -2723000 USD |
| Diluted EPS (ttm) | -0.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.26M USD |
| Total Cash Per Share (mrq) | 2.15 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.116 |
| Book Value Per Share (mrq) | 1.135 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4883000 USD |
| Levered Free Cash Flow (ttm) | -4870125 USD |
Profile of Mustang Bio
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 95 Sawyer Road |
| ZIP | 02453 |
| Phone | 781 652 4500 |
| Website | https://www.mustangbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Q&A For Mustang Bio Stock
What is a current MBIO stock price?
Mustang Bio MBIO stock price today per share is 0.7 USD.
How to purchase Mustang Bio stock?
You can buy MBIO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mustang Bio?
The stock symbol or ticker of Mustang Bio is MBIO.
Which industry does the Mustang Bio company belong to?
The Mustang Bio industry is Biotechnology.
How many shares does Mustang Bio have in circulation?
The max supply of Mustang Bio shares is 7.58M.
What is Mustang Bio Price to Earnings Ratio (PE Ratio)?
Mustang Bio PE Ratio is now.
What was Mustang Bio earnings per share over the trailing 12 months (TTM)?
Mustang Bio EPS is -0.48 USD over the trailing 12 months.
Which sector does the Mustang Bio company belong to?
The Mustang Bio sector is Healthcare.
Mustang Bio MBIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25476.64 USD — |
-0.43
|
14.18B USD — | 25354.66 USD — | 25840.56 USD — | — - | 14.18B USD — |
|
US Tech Health Care
IXHC
US
|
1203.64 USD — |
+1.6
|
— — | 1192.12 USD — | 1213.64 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2297.61 USD — |
-0.55
|
— — | 2291.88 USD — | 2327.27 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6279.39 USD — |
+1.52
|
— — | 6222.02 USD — | 6337.86 USD — | — - | — — |
- {{ link.label }} {{link}}